Dr Singh gave a presentation at the 3rd European Phenylketonuria Group Symposium in Lisbon, Portugal (March 2011) focused on the work she and her research group are currently undertaking to evaluate the emerging alternative and adjunct therapies for patients with PKU. Afterwards, she spoke to us about her current research interests looking at the effects of BH4; neuromarkers; developing a classification for BH4 responders and validating a home Phe monitoring system that is being developed.
Login
We offer our registered users tailored information, free online courses and exclusive content.
You have an old EXCEMED account ...
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?